Friday, August 31, 2012

Reaching Healthcare Providers While Remaining Compliant

Thought Leader: Erez Lapsker, CEO, MediScripts

In this episode, Mr. Lapsker discusses how adaptability is necessary to remaining a viable and successful business in an era of regulatory change. He also explains how all forms of marketing to HCPs are not equal.

For more information about MediScripts, visit
www.mediscripts.com.


For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Global Biosimilar Development

Thought Leader: Rodeina Challand, Executive Director, Biosimilars Development, PRA International

In this episode, Rodeina Challand clears up some of the murkiness among the many terms associated with biosimilars. Then, we cover the legislation and guidelines affecting biosimilars, we discuss the possibilities of one global program, and finally talk about the future for a global standard.

For more information about PRA International, visit
www.prainternational.com.


For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Future of Pharmacovigilance: Five Imperatives that will Drive Improved Business

Thought Leaders: Nagaraja Srivatsan, SVP, Head of Life Sciences, North America at Cognizant Venkat Venkataramanan, Director, Pharmacovigilance Domain Head, Cognizant, George Botsakos, Senior Director and Life Sciences R&D Leader in Cognizant's Business Consulting group

In this episode, our panel discusses pharmacovigilance as it relates to organizational transformation. The podcast covers collaboration, capacity management, globalization, information and analytics, and transparency and trust.

For more information about Cognizant, visit
www.cognizant.com.


For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.